SUMO1 抗体
Quick Overview for SUMO1 抗体 (ABIN6297549)
抗原
See all SUMO1 抗体适用
宿主
克隆类型
标记
应用范围
-
-
原理
- Mouse anti-Human/Mouse/Rat SUMO1 Antibody [Sodium Azide Free]
-
特异性
- Predominantly nuclear with some cytoplasmic
-
纯化方法
- Recombinant human protein was used as the immunogen for this SUMO1 antibody.
-
免疫原
- Recombinant human protein was used as the immunogen for this SUMO1 antibody.
-
-
-
-
应用备注
-
FACS: 0.5-1 μg/million cells
IF: 0.5-1 μg/mL
WB: 0.5-1 μg/mL
IHC (FFPE): 0.5-1 μg/mL for 30 minutes at RT (1)
Prediluted format: incubate for 30 min at RT (2) -
限制
- 仅限研究用
-
-
-
缓冲液
- In 1X PBS ( pH 7.4), BSA free, sodium azide free
-
储存液
- Azide free
-
储存条件
- 4 °C,-20 °C
-
储存方法
- 2-8°C. The azide-free format should be aliquoted and stored at -20°C or colder.
-
-
- SUMO1 (Small Ubiquitin Related Modifier Protein 1 (SUMO1))
-
别名
- Small ubiquitin-related modifier 1
-
背景
-
Target Description: The small ubiquitin-related modifier (SUMO) proteins, which include SUMO1, 2 and 3, belong to the ubiquitin-like protein family. Like ubiquitin, the SUMO proteins are synthesized as precursor proteins that undergo processing before conjugation to target proteins. However, SUMO and ubiquitin differ with respect to targeting. Ubiquitination predominantly targets proteins for degradation, whereas sumoylation targets proteins to a variety of cellular processing, including nuclear transport, transcriptional regulation, apoptosis and protein stability.
Gene Symbol: SUMO1///SMT3C///SMT3H3///UBL1///OK///SW-cl.43
-
基因ID
- 7341
-
UniProt
- P63165
-
途径
- M Phase, Positive Regulation of Endopeptidase Activity, Protein targeting to Nucleus, Ubiquitin Proteasome Pathway
抗原
-